Abbott, GSK Pen Melanoma MDx Collaboration

Abbott will develop a molecular PCR-based test aimed at identifying patients who may benefit from a GSK drug for melanoma.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.